Naurex
AcquiredEvanston, United States · Founded 2006 · $136.0M raised
- Headquarters
- Evanston, Illinois
- Employees
- 11–50
- Founded
- 2006
- Business Model
- B2B
- Total Funding
- $136.0M
- Last Round
- $80.0M Series CDec 2014
- Rounds
- 3
- Acquisition Date
- Jul 2015
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Naurex was a biopharmaceutical company developing novel NMDA receptor modulators to treat central nervous system diseases, including depression. Founded in 2006 as a Northwestern University spinoff, it was acquired by Allergan in 2015 for $560 million.
Summary
Naurex is a Biotech company based in Evanston, United States, founded in 2006. It has raised $136.0M in total across 3 rounds, most recently a $80.0M Series C round in Dec 2014. Investors include Baxter Ventures, Adams Street Partners and Cowen.
Funding & Exit History
Jul 2015
Sign up to see all 4 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/naurex"><img src="https://indexed.vc/api/badge/company/naurex" alt="Naurex on Indexed.vc" width="260" height="76" /></a>